Tempus Q3 revenue hits $411.5M, beats estimates
Tempus reported record third quarter revenue of $411.5 million, raising full-year guidance. The company also announced major strategic collaborations with Merck, Moderna, and Bristol Myers Squibb.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed